Free Trial
OTCMKTS:HCYTD

H-CYTE (HCYTD) Stock Price, News & Analysis

H-CYTE logo
$2.02 -1.98 (-49.50%)
As of 07/11/2022

About H-CYTE Stock (OTCMKTS:HCYTD)

Key Stats

Today's Range
$2.02
$2.77
50-Day Range
$2.02
$2.02
52-Week Range
$2.02
$77.00
Volume
400 shs
Average Volume
103 shs
Market Capitalization
$521,160.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Receive HCYTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H-CYTE and its competitors with MarketBeat's FREE daily newsletter.

HCYTD Stock News Headlines

Hydro One Limited (H.TO)
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
W.H. Hamilton Struck by a Train.
H&R Block Coupons February 2024
Hyatt Hotels Corp Class A H
See More Headlines

HCYTD Stock Analysis - Frequently Asked Questions

H-CYTE's stock was trading at $2.02 at the beginning of 2025. Since then, HCYTD stock has increased by 0.0% and is now trading at $2.02.
View the best growth stocks for 2025 here
.

Shares of HCYTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:HCYTD
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.80 million
Net Margins
-450.40%
Pretax Margin
-450.40%

Debt

Sales & Book Value

Annual Sales
$1.61 million
Price / Cash Flow
N/A
Book Value
($31.45) per share
Price / Book
-0.06

Miscellaneous

Free Float
244,000
Market Cap
$521,160.00
Optionable
Not Optionable
Beta
1.12
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:HCYTD) was last updated on 6/2/2025 by MarketBeat.com Staff
From Our Partners